Skip to main content
TipRanks
Go Ultimate75% OFF

ScandiDos AB (SDOS) AI Stock Analysis

0 Followers
SE:SDOS

ScandiDos AB

(Nasdaq OMX AB:SDOS)

Select Model
Rating:40Underperform
Price Target:SEK 0.42â–¼(-5.00% Downside)
Action:downgraded
Date:11/07/26

The stock scores poorly due to a combination of declining revenues, persistent unprofitability, and negative cash flows, which are the most significant risks. Technicals reinforce this weakness with a strong downtrend and oversold conditions. The debt-free balance sheet offers some mitigation but is insufficient to offset the operational and market challenges.

Positive Factors
Conservative Balance SheetVery low reported debt relative to equity gives ScandiDos financial flexibility and reduces near-term solvency pressure. This stronger balance-sheet position can help the company sustain investment in its radiotherapy QA offering while operating performance remains under development.
Negative Factors
Declining RevenueRevenue contraction indicates that the company has not recently expanded its commercial base, increasing pressure on a small specialist business to fund product development and operating costs. Continued decline would make it harder to achieve scale and improve profitability over the next several quarters.

ScandiDos AB (SDOS) vs. iShares MSCI Sweden ETF (EWD)

-60%-40%-20%0%20%SE:SDOS-58.10%EWD+15.64%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 31.36M
Dividend Yield
―
Average Volume (3M)
77.27K
Price to Earnings (P/E)
-3.6
Beta (1Y)
0.34
Revenue Growth
-19.44%
EPS Growth
-475.48%
Country
Sweden
Employees
25
Sector
General
Sector Strength
55
Industry
Medical - Devices

ScandiDos AB Business Overview & Revenue Model

Company Description

ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internat...

ScandiDos AB Financial Statement Overview

Summary

Financial performance is weak, driven by an 8% TTM revenue decline, compressed gross margins (56% vs. 79%+ historically), and persistent net losses. The debt-free balance sheet provides stability, but negative operating and free cash flow highlight ongoing cash burn. The overall financial health is poor, with no clear path to profitability.

Income Statement

18Very Negative

Balance Sheet

65Positive

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMApr 2025Apr 2024Apr 2023Apr 2023Apr 2021
Income Statement
Total Revenue49.97M54.22M60.43M61.55M60.43M59.99M
Gross Profit28.15M-2.71M47.55M52.95M47.55M49.73M
EBITDA-5.05M-439.00K-11.77M-3.00M-11.11M2.85M
Net Income-8.21M-3.44M-14.65M-9.12M-14.65M-1.40M
Balance Sheet
Total Assets72.08M65.97M73.38M72.42M81.47M77.16M
Cash, Cash Equivalents and Short-Term Investments16.00M4.36M10.06M3.55M1.53M9.00M
Total Debt2.32M000083.00K
Total Liabilities24.92M24.31M28.40M30.77M37.19M31.98M
Stockholders Equity47.16M41.66M44.98M41.65M44.29M45.18M
Cash Flow
Free Cash Flow-4.50M-6.79M-2.71M-16.31M-1.46M4.08M
Operating Cash Flow-2.79M-2.92M230.00K-11.90M1.49M8.64M
Investing Cash Flow-3.84M-3.87M-2.94M-4.37M-2.94M-4.63M
Financing Cash Flow11.66M0012.33M0-1.66M

ScandiDos AB Technical Analysis

Technical Analysis SentimentNegative
Last Price0.44

Price Trends

50DMA0.63Negative
100DMA0.74Negative
200DMA0.85Negative

Market Momentum

MACD-0.05Positive
RSI18.42Positive
STOCH12.49Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SDOS, the sentiment is Negative. The current price of 0.44 is below the 20-day moving average (MA) of 0.54, below the 50-day MA of 0.63, and below the 200-day MA of 0.85, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 18.42 is Positive, neither overbought nor oversold. The STOCH value of 12.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SDOS.

ScandiDos AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

SE:SDOS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:SECT.BSE:SECT.B74OutperformSEK 62.79B98.4130.26%0.71%13.94%5.70%
SE:PAXSE:PAX60NeutralSEK 1.57B-309.35-1.22%―34.05%-144.96%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
SE:OSSDSE:OSSD45NeutralSEK 387.19M-7.74――-11.89%-11.85%
SE:SCIBSE:SCIB40UnderperformSEK 135.27M-0.71-303.61%―54.94%47.64%
SE:SPECSE:SPEC40UnderperformSEK 19.54M-0.11-57.15%――78.15%
SE:SDOSSE:SDOS40UnderperformSEK 31.36M-3.59――-19.44%-475.48%

* General Sector Average

Performance Comparison

-50%0%50%100%SE:SDOSSE:PAXSE:SCIBSE:SPECSE:SECT.BSE:OSSDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SE:SDOS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:SDOSScandiDos AB0.44-0.62-58.49%
SE:PAXPaxman AB67.506.9011.39%
SE:SCIBSciBase Holding AB9.58-10.31-51.83%
SE:SPECSpectraCure AB0.01-0.12-90.08%
SE:SECT.BSectra AB Class B321.8036.4812.78%
SE:OSSDOssDsign AB3.50-7.48-68.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026